Samuel Agresta

Insider Reports History

Entity
Individual
Location
784 Memorial Dr., Cambridge, MA
Signature
/s/ Rogan Nunn, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Samuel Agresta:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Foghorn Therapeutics Inc. Chief Medical Officer Stock Options (Right to buy) 60K $184K $3.06 Sep 11, 2023 Direct
INFINITY PHARMACEUTICALS, INC. Director Stock Option(right to buy) 45K Jun 16, 2022 Direct
OnKure Therapeutics, Inc. Chief Medical Officer Employee Stock Option (right to buy) 45K Jan 27, 2025 Direct
Foghorn Therapeutics Inc. Chief Medical Officer Common Stock 0 $8.25 Aug 16, 2023 Direct

Insider Reports Filed by Samuel Agresta

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OKUR OnKure Therapeutics, Inc. Jan 27, 2025 1 $0 4 Jan 29, 2025 Chief Medical Officer
OKUR OnKure Therapeutics, Inc. Oct 4, 2024 2 $0 4 Oct 8, 2024 Chief Medical Officer
OKUR OnKure Therapeutics, Inc. Oct 4, 2024 0 $0 3 Oct 8, 2024 Chief Medical Officer
FHTX Foghorn Therapeutics Inc. Sep 11, 2023 0 $0 4 Sep 13, 2023 Chief Medical Officer
FHTX Foghorn Therapeutics Inc. Aug 16, 2023 3 -$1.41M 4 Aug 18, 2023 Chief Medical Officer
FHTX Foghorn Therapeutics Inc. Jan 26, 2023 1 $0 4 Jan 30, 2023 Chief Medical Officer
INFI INFINITY PHARMACEUTICALS, INC. Jun 16, 2022 1 $0 4 Jun 16, 2022 Director
FHTX Foghorn Therapeutics Inc. Jan 26, 2022 1 $0 4 Jan 28, 2022 Chief Medical Officer
INFI INFINITY PHARMACEUTICALS, INC. Jun 10, 2021 1 $0 4 Jun 11, 2021 Director